	Design, synthesis and anti-Parkinson's disease bioactivity evaluation of isoquinoline derivatives as potent IDO1/TDO dual inhibitors. Bioorg Med Chem Lett Yang Z, Lin Z, Yang C, Lu R, Wu Y. PMID: 41734858 [PubMed - as supplied by publisher]
	Bibliometric analysis of the pathogenesis of Parkinson's Disease. Pathol Res Pract Feng Y, Wang K, Guo X, Guo H, Gao X. PMID: 41734603 [PubMed - as supplied by publisher]
	The structure of personality in Parkinson's disease and the effects of age, years since diagnosis, and impulsivity. PeerJ Vicentin S, Chiriatti L, Cona G. PMID: 41732724 [PubMed - indexed for MEDLINE]
	Progress in the study of ion channel function, mechanisms, and mathematical modeling in Parkinson's disease. iScience Wang R, Zeng X, Zhang Z, Ma D. PMID: 41732483 [PubMed]
	Longitudinal Neuroimaging Reveals Divergent Clinical Associations of Glymphatic Dysfunction and Dopaminergic Degeneration in Parkinson's Disease. Hum Brain Mapp Liu T, Shen Y, Bai Y, Gao S, Meng N, Wei W, Roberts N, Wang M. PMID: 41731626 [PubMed - indexed for MEDLINE]
	In-person when necessary and available, remotely when possible - How telemedicine can support palliative care for persons with Parkinson's disease: a qualitative study. BMC Palliat Care van den Bergh R, Muente C, van Barschot P, Bloem BR, Meinders MJ. PMID: 41731460 [PubMed - as supplied by publisher]
	Relationship between frailty and disease progression in Parkinson's disease: a 3-year longitudinal study. Geroscience Costanzo M, Canevelli M, De Bartolo MI, Valletta M, Marchet F, Blasi MT, Leodori G, Conte A, Bruno G, Fabbrini G, Belvisi D. PMID: 41731291 [PubMed - as supplied by publisher]
	Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative Study. Mov Disord Papagiannakis N, Koros C, Simitsi AM, Stefanis L, and The Parkinson's Progression Markers Initiative. PMID: 41730696 [PubMed - as supplied by publisher]
	Predictive Factors and Impact of Significant Weight Loss on Quality of Life in Parkinson's Disease: A 5-Year Follow-Up Study. Mov Disord Clin Pract Vidal ÁS, Santos-García D, de Deus Fonticoba T, Jesús S, Cosgaya M, Caldentey JG, Caballol N, Legarda I, Vara JH, Cabo I, Manzanares LL, Aramburu IG, Rivera AA, Mayordomo VG, Nogueira V, García-Soto JD, Borrué C, Vila BS, Sauco MÁ, Mir P, COPPADIS Study Group. PMID: 41730672 [PubMed - as supplied by publisher]
	How cytochrome P450 enzymes in humans are involved in Parkinson's disease: a literature review. Neuroscience Ren B, Yan H, Han C, Sun S, Wang D, Xu Y, Xie J. PMID: 41730497 [PubMed - as supplied by publisher]
	Gene therapy targeting synaptopathy linked with Alzheimer's and Parkinson's disease. Neuroscience Panda SP, Saraswat N, Singh V. PMID: 41730496 [PubMed - as supplied by publisher]
	Parkinson's Disease Biomarkers: Bridging the Gap Between Diagnosis and Treatment. Behav Brain Res Chakkarwar VA, Kulkarni YA. PMID: 41730457 [PubMed - as supplied by publisher]
	Trustworthy AI for medical decisions: Adversarially robust and fair machine learning prediction for Parkinson's disease. PLoS One Muhammad J, Ghergherehchi M, Ali S, Seung Song H, Rahim N. PMID: 41729985 [PubMed - indexed for MEDLINE]
	Multimodal Machine Learning and Deep Learning Approaches for Parkinson's Disease Diagnosis: A Comprehensive Survey. Clin EEG Neurosci Ahmed AN, Mohammed AS, Yousif Potrus M. PMID: 41729683 [PubMed - as supplied by publisher]
	Causal Effects Between Antibody-Mediated Immune Responses and Parkinson's Disease: Insights from Genetic Studies. Cureus Yu F, Cai R. PMID: 41728547 [PubMed]
	Predictive modeling of vocal biomarkers for the diagnosis of Parkinson's disease. Cogn Neurodyn Emegano DI, Mustapha MT, Isaac EP, Ozsahin I, Uzun B, Ozsahin DU. PMID: 41728211 [PubMed]
	PARQ: A Complexity-Consensus Aware Automatic Assessment of Motor Disease Severity in Parkinson's Disease. Res Sq Chakraborty I, Trushenski K, Khan SS, Taneff Y, Tarakad A, Anandan C, Bellows ST, Yilmaz AY, Balakrishnan G, Vanegas-Arroyave N, Sabharwal A. PMID: 41727589 [PubMed]
	Microglia heterogeneity and therapeutic strategies in Parkinson's disease. Front Immunol Tian J, Liu X, Wang Z, Shi X, Dai C, Yang L. PMID: 41727462 [PubMed - indexed for MEDLINE]
	Advancing the Treatment of Motor Fluctuations in Parkinson's Disease with a Next-Generation Levodopa/Carbidopa Formulation. Neurol Ther Stocchi F, Knecht M, Marjanovic I, Wach A, Kopra J, Kulisevsky J. PMID: 41724884 [PubMed - as supplied by publisher]
	White matter alterations in right-onset versus left-onset Parkinson's disease in an early stage. Behav Brain Res Li X, Tan C, Cai S, Liu Q, Wang M, Liu Y, Yuan J, Tang Y, Niu Y, Huang C, He W, Shen Q, Liao H. PMID: 41724446 [PubMed - as supplied by publisher]

Articles 1 - 20 / 56563

Page 1 of 2829



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy